Combined MEK and VEGFR Inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis

PURPOSE: Ras/Raf/MEK/ERK signaling is critical for tumor cell proliferation and survival. Selumetinib is a potent, selective, and orally available MEK1/2 inhibitor. In the current study, we evaluated the therapeutic efficacy of selumetinib alone or with cediranib, an orally available potent inhibito...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Takahashi, Osamu, Komaki, Ritsuko, Smith, Paul D., Jürgensmeier, Juliane M., Ryan, Anderson, Bekele, B. Nebiyou, Wistuba, Ignacio I., Jacoby, Jörg J., Korshunova, Maria V., Biernacka, Anna, Erez, Baruch, Hosho, Keiko, Herbst, Roy S., O’Reilly, Michael S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306446/
https://ncbi.nlm.nih.gov/pubmed/22275507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados